Consensus Moderna, Inc.

Equities

MRNA

US60770K1079

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
108.8 ^USD	+0.89%		+5.23%	+9.45%

10:00pm	Sector Update: Health Care Stocks Slipping Late Afternoon	MT
05:37pm	Moderna to Collaborate With OpenAI to Launch New Generation of Medicines	MT

Evolution of the average Target Price on Moderna, Inc.

Price target over the last 5 years

History of analyst recommendation changes

a73891a9d.KCWVi0gsusAV6R5xpEbsdiuUNLc0Z-eB2PirK9sWfs0.HWfz4yRtz_hRri5J3n_aMWrwUuFaA4zGtamYQu9TE6NZX9zIA2vAuGy2Vw~633740effe27d01907b80a7d19088ef4

Analyst Recommendations on Moderna, Inc.

Moderna Secures Contract to Supply 12.5 Million COVID-19 Vaccine Doses to Brazil	Apr. 22	MT
Moderna Insider Sold Shares Worth $1,575,300, According to a Recent SEC Filing	Apr. 16	MT
Redburn Adjusts Moderna's Price Target to $117 From $110	Apr. 12	MT
MODERNA : Jefferies confirms its Buy recommendation	Apr. 09	CF
HSBC Downgrades Moderna to Reduce From Hold, Raises Price Target to $86 From $75	Feb. 26	MT
ANALYST RECOMMENDATIONS : AbbVie, Doordash, Eli Lilly, Moderna, Hiscox...	Feb. 26
Canaccord Genuity Raises Moderna's Price Target to $91 From $82, Keeps Hold Rating	Feb. 23	MT
MODERNA : RBC keeps its Buy rating	Jan. 12	ZD
WHO sees 'incredibly low' COVID, flu vaccination rates as cases surge	Jan. 12	RE
Investors lower their expectations	Jan. 08
Stocks Decline Pre-Bell as Fed Outlook, Rates Weigh; Asia, Europe Down	Jan. 03	MT
Oppenheimer Upgrades Moderna to Outperform From Perform, Price Target is $142	Jan. 02	MT
Stocks finish higher again after Fed pivots on rates	Dec. 14	RE
Health Care Drops on Rotation to Rate-Sensitive Sectors - Health Care Roundup	Dec. 14	DJ
Wall St set for higher open after Fed hints at rate cuts	Dec. 14	RE
Morgan Stanley Cuts Price Target on Moderna to $92 From $115, Keeps Equalweight Rating	Dec. 12	MT
ANALYST RECOMMENDATIONS : Adobe, Amgen, Blackrock, IBM, Ulta Beauty...	Dec. 12
ANALYST RECOMMENDATIONS : Adobe, Apple, Broadcom, Lululemon, Relx...	Dec. 08
JPMorgan Adjusts Moderna Price Target to $90 From $93, Maintains Neutral Rating	Dec. 01	MT
Canaccord Genuity Starts Moderna With Hold Rating, Price Target is $82	Nov. 29	MT
UBS Lowers Moderna's Price Target to $143 From $178, Keeps Buy Rating	Nov. 06	MT
HSBC Upgrades Moderna to Hold From Reduce, Adjusts Price Target to $69 From $89	Nov. 03	MT
Goldman Sachs Cuts Price Target on Moderna to $231 From $269, Maintains Buy Rating	Nov. 03	MT
RBC Cuts Price Target on Moderna to $125 From $180, Keeps Outperform Rating	Nov. 03	MT
MODERNA : Goldman Sachs reaffirms its Buy rating	Nov. 03	ZD

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

107.9 USD

Average target price

134.3 USD

Spread / Average Target

+24.48%

High Price Target

310 USD

Spread / Highest target

+187.33%

Low Price Target

59 USD

Spread / Lowest Target

-45.31%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Moderna, Inc.

Redburn
HSBC
Canaccord Genuity
RBC	Luca Issi
Oppenheimer
Morgan Stanley
JPMorgan Chase
UBS
Goldman Sachs
RBC Capital Markets
Deutsche Bank Securities
Argus
TD Cowen
William Blair & Co.
Guggenheim
SVB Securities LLC
Cowen
Chardan Research
Piper Sandler
Jefferies & Co.
SVB Leerink
BofA Securities
Wolfe Research
Barclays
Chardan
J.P. Morgan Chase

Ratings for Moderna, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar